Table 1.

Demographic and clinical characteristics of patients with MIS-C and KDSS.

	MIS-C	KDSS
Age	64.5% >5 years of age	44.7% >5 years of age
Race	Hispanic, afro descendant	Hispanic
Kawasaki disease features	40%	100%
GI manifestations	Frequent	Frequent
Neurological symptoms	Frequent	Frequent
Cardiac involvement	Cardiac failure, valvular regurgitation, pericarditis, coronary artery abnormalities (aneurysms less frequent)	Cardiac failure, valvular regurgitation, pericarditis, coronary artery abnormalities (frequent coronary aneurysms)
Albumin	Low	Low
D-dímers	Elevated	Elevated
Platelets	Low	Low
proBNP	Elevated	Elevated
Ferritin	Elevated	¿
Treatment	Corticosteroids, IVIG, infliximab, anakinra, tocilizumab, plasmapheresis, larazotide?	Corticosteroids, IVIG, cyclosporin, plasmapheresis, infliximab, anakinra
Mortality	2%	6.8%

KDSS = Kawasaki disease shock syndrome, data are from references 2 and 3; MIS-C = Multisystemic inflammatory syndrome in children.